These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 35698213)

  • 1. Study protocol for developing, piloting and disseminating the PRISMA-COSMIN guideline: a new reporting guideline for systematic reviews of outcome measurement instruments.
    Elsman EBM; Butcher NJ; Mokkink LB; Terwee CB; Tricco A; Gagnier JJ; Aiyegbusi OL; Barnett C; Smith M; Moher D; Offringa M
    Syst Rev; 2022 Jun; 11(1):121. PubMed ID: 35698213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.
    Elsman EBM; Mokkink LB; Terwee CB; Beaton D; Gagnier JJ; Tricco AC; Baba A; Butcher NJ; Smith M; Hofstetter C; Aiyegbusi OL; Berardi A; Farmer J; Haywood KL; Krause KR; Markham S; Mayo-Wilson E; Mehdipour A; Ricketts J; Szatmari P; Touma Z; Moher D; Offringa M
    Health Qual Life Outcomes; 2024 Jul; 22(1):48. PubMed ID: 38978063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.
    Elsman EBM; Mokkink LB; Terwee CB; Beaton D; Gagnier JJ; Tricco AC; Baba A; Butcher NJ; Smith M; Hofstetter C; Aiyegbusi OL; Berardi A; Farmer J; Haywood KL; Krause KR; Markham S; Mayo-Wilson E; Mehdipour A; Ricketts J; Szatmari P; Touma Z; Moher D; Offringa M
    J Patient Rep Outcomes; 2024 Jul; 8(1):64. PubMed ID: 38977535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.
    Elsman EBM; Mokkink LB; Terwee CB; Beaton D; Gagnier JJ; Tricco AC; Baba A; Butcher NJ; Smith M; Hofstetter C; Aiyegbusi OL; Berardi A; Farmer J; Haywood KL; Krause KR; Markham S; Mayo-Wilson E; Mehdipour A; Ricketts J; Szatmari P; Touma Z; Moher D; Offringa M
    Qual Life Res; 2024 Aug; 33(8):2029-2046. PubMed ID: 38980635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.
    Elsman EBM; Mokkink LB; Terwee CB; Beaton D; Gagnier JJ; Tricco AC; Baba A; Butcher NJ; Smith M; Hofstetter C; Lee Aiyegbusi O; Berardi A; Farmer J; Haywood KL; Krause KR; Markham S; Mayo-Wilson E; Mehdipour A; Ricketts J; Szatmari P; Touma Z; Moher D; Offringa M
    J Clin Epidemiol; 2024 Jul; ():111422. PubMed ID: 38849061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).
    Butcher NJ; Monsour A; Mew EJ; Szatmari P; Pierro A; Kelly LE; Farid-Kapadia M; Chee-A-Tow A; Saeed L; Monga S; Ungar W; Terwee CB; Vohra S; Fergusson D; Askie LM; Williamson PR; Chan AW; Moher D; Offringa M
    Trials; 2019 Mar; 20(1):161. PubMed ID: 30841935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A blueprint for patient and public involvement in the development of a reporting guideline for systematic reviews of outcome measurement instruments: PRISMA-COSMIN for OMIs 2024.
    Elsman EBM; Smith M; Hofstetter C; Gavin F; Jobson E; Markham S; Ricketts J; Baba A; Butcher NJ; Offringa M
    Res Involv Engagem; 2024 Mar; 10(1):33. PubMed ID: 38515153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement.
    McInnes MDF; Moher D; Thombs BD; McGrath TA; Bossuyt PM; ; Clifford T; Cohen JF; Deeks JJ; Gatsonis C; Hooft L; Hunt HA; Hyde CJ; Korevaar DA; Leeflang MMG; Macaskill P; Reitsma JB; Rodin R; Rutjes AWS; Salameh JP; Stevens A; Takwoingi Y; Tonelli M; Weeks L; Whiting P; Willis BH
    JAMA; 2018 Jan; 319(4):388-396. PubMed ID: 29362800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for reporting pediatric and child health clinical trial protocols and reports: study protocol for SPIRIT-Children and CONSORT-Children.
    Baba A; Smith M; Potter BK; Chan AW; Moher D; Offringa M
    Trials; 2024 Jan; 25(1):96. PubMed ID: 38287439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric properties of disease-specific health-related quality of life (HRQoL) instruments for food allergy and food intolerance: protocol for a COSMIN-based systematic review.
    Chen Q; Li Z; Castro A; Tang S; Chen J; Huang C; Xiao J; Liu H; Ding J
    BMJ Open; 2022 Jan; 12(1):e053534. PubMed ID: 35039295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement.
    Gates M; Gates A; Pieper D; Fernandes RM; Tricco AC; Moher D; Brennan SE; Li T; Pollock M; Lunny C; Sepúlveda D; McKenzie JE; Scott SD; Robinson KA; Matthias K; Bougioukas KI; Fusar-Poli P; Whiting P; Moss SJ; Hartling L
    BMJ; 2022 Aug; 378():e070849. PubMed ID: 35944924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRISMA-Children (C) and PRISMA-Protocol for Children (P-C) Extensions: a study protocol for the development of guidelines for the conduct and reporting of systematic reviews and meta-analyses of newborn and child health research.
    Kapadia MZ; Askie L; Hartling L; Contopoulos-Ioannidis D; Bhutta ZA; Soll R; Moher D; Offringa M
    BMJ Open; 2016 Apr; 6(4):e010270. PubMed ID: 27091820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential items for reporting of scaling studies of health interventions (SUCCEED): protocol for a systematic review and Delphi process.
    Gogovor A; Zomahoun HTV; Ben Charif A; McLean RKD; Moher D; Milat A; Wolfenden L; Prévost K; Aubin E; Rochon P; Ekanmian G; Sawadogo J; Rheault N; Légaré F
    Syst Rev; 2020 Jan; 9(1):11. PubMed ID: 31926555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies: The AGReMA Statement.
    Lee H; Cashin AG; Lamb SE; Hopewell S; Vansteelandt S; VanderWeele TJ; MacKinnon DP; Mansell G; Collins GS; Golub RM; McAuley JH; ; Localio AR; van Amelsvoort L; Guallar E; Rijnhart J; Goldsmith K; Fairchild AJ; Lewis CC; Kamper SJ; Williams CM; Henschke N
    JAMA; 2021 Sep; 326(11):1045-1056. PubMed ID: 34546296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol of the COSMIN study: COnsensus-based Standards for the selection of health Measurement INstruments.
    Mokkink LB; Terwee CB; Knol DL; Stratford PW; Alonso J; Patrick DL; Bouter LM; de Vet HC
    BMC Med Res Methodol; 2006 Jan; 6():2. PubMed ID: 16433905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.
    Calvert M; Kyte D; Mercieca-Bebber R; Slade A; Chan AW; King MT; ; Hunn A; Bottomley A; Regnault A; Chan AW; Ells C; O'Connor D; Revicki D; Patrick D; Altman D; Basch E; Velikova G; Price G; Draper H; Blazeby J; Scott J; Coast J; Norquist J; Brown J; Haywood K; Johnson LL; Campbell L; Frank L; von Hildebrand M; Brundage M; Palmer M; Kluetz P; Stephens R; Golub RM; Mitchell S; Groves T
    JAMA; 2018 Feb; 319(5):483-494. PubMed ID: 29411037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension.
    Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
    JAMA; 2022 Dec; 328(23):2345-2356. PubMed ID: 36512367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement.
    Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Moher D
    J Clin Epidemiol; 2021 Jun; 134():103-112. PubMed ID: 33577987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.
    Stewart LA; Clarke M; Rovers M; Riley RD; Simmonds M; Stewart G; Tierney JF;
    JAMA; 2015 Apr; 313(16):1657-65. PubMed ID: 25919529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.